Trends in Radiopharmaceuticals (ISTR-2005). Proceedings of an International Symposium. Vol. 2

The growth of nuclear medicine depends on advances in radiopharmaceutical development and discovery, as well as improvements in instrumentation. The field of radiopharmaceuticals has witnessed continuous evolution thanks to the contributions of scientists from diverse disciplines such as chemistry, physiology and pharmacology. The IAEA has been supporting activities in the field of radiopharmaceuticals, which has resulted in significant capacity building in the above fields in Member States. Many Member States have developed manufacturing facilities through technical cooperation projects for the large scale production of radiopharmaceuticals which helped the growth of nuclear medicine in those countries. IAEA efforts through coordinated research projects have also helped in advancing research activities in the development and utilization of new products in many Member States. The International Symposium on Trends in Radiopharmaceuticals (ISTR-2005) was organized in order to provide scientists and professionals from 70 countries working in the field of radiopharmaceuticals and related sciences with the opportunity to present their research to an international audience. Sessions covered the most relevant topics of radiopharmaceuticals chemistry, including radionuclide production, radiochemical processing, manufacturing and quality control, quality assurance, latest advances in radiopharmaceuticals research, good manufacturing practices and regulatory aspects. On the basis of the invited presentations, papers and panel discussions during ISTR-2005, several areas of possible future international cooperation were identified. This publication comprises two volumes and constitutes a record of the symposium and includes a summary as well as invited papers presented. A CD-ROM containing the unedited contributed papers which were presented in the two poster sessions of the symposium is included in volume 2.